Ultima Genomics is unleashing the power of genomics at scale. The company's mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in genomic research. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists are forced to make between the breadth, depth, and frequency with which they use genomic information. Ultima Genomics’ novel massively parallel sequencing platform, the UG 100™, combines multiple innovative technologies, including an open flow cell design, a mostly natural chemistry that uses nucleotides without reversible terminators, and optical end-point detection, all to enable the sequencing of billions of reads with longer read lengths (~300 bp) and fast run times (<20 hrs) at high accuracy (Q30 > 85%) and a low cost of $1/Gb.